From plant to patient: An ethnomedical approach to the identification of new drugs for the treatment of NIDDM

Diabetologia

Volumn 40, Issue 5, 1997, Pages 614-617

  Oubre A Y ^a   Carlson, T J ^a   King, S R ^a   Reaven, G M ^a  

^a Shaman Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; METFORMIN;

DRUG SCREENING; ETHNOLOGY; HUMAN; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SHORT SURVEY;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; MEDICINE, TRADITIONAL; PHYTOTHERAPY; PLANTS, MEDICINAL; REPRODUCIBILITY OF RESULTS;

EID: 0030903290     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050724     Document Type: Short Survey

References (23)

1. Farnsworth NR (1994) Ethnopharmacology and drug development. In: Chadwick DJ, Marsh J (eds) Ethnobotany and the search for new drugs Ciba Foundation Symposium 185. John Wiley and Sons, Chichester New York, pp 42-51
2. Farnsworth NR (1990) The role of ethnopharmacology in drug development. In: Chadwick DJ, Marsh J (eds) Bioactive compounds from plants. Ciba Foundation Symposium 154. John Wiley and Sons, Chichester New York, pp 2-11
3. Oliver Bever B, Zahnd GR (1979) Plants with oral hypoglycemic action. Quarterly Journal of crude Drug Research 17: 139-196
4. Bailey CJ, Day C (1989) Traditional plant medicines as treatments for diabetes. Diabetes Care 12: 553-564
5. Ivorra MD, Paya M, Villar A (1989) A review of natural products and plants as potential antidiabetic drugs. Journal of Ethnopharmacology. 27: 243-275
6. Maries RJ, Farnsworth NR (1995) Antidiabetic plants and their active constituents. Phytomedicine. 2: 137-189
7. Massengill SE (1943) A sketch of medicine and pharmacy. S. E. Massengill company, Bristol, Tennesse
8. Dahanikar S, Thatte U (1989) Ayurveda revisited. Popular Prakashan Bombay
9. Ackerknecht EH (1982) A short history of medicine (Revised edition) Johns Hopkins University Press, Baltimore/ London
10. Watanabe CK (1981) Studies in the metabolic changes induced by administration of guanidine basis. I. Influence of injected guanidine hydrochloride upon blood sugar content. J Biol Chem 33: 253-265
11. Sterne J (1957) Du nouveau dans les antidiabetiques, 1a NN dimethylamino guanyl guanidine (NNDG). Maroc Med. 36: 1295-1296
12. Ungar G (1957) Pharmacological studies of a new oral hypoglycemic drug. Proc Soc Exp Biol Med. 95: 190-192
13. Thorburn AW, Gumbiner B, Bulacan F, Brechtel G, Henry RR (1991) Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin-dependent diabetes mellitus. J Clin Invest 87:4 89-495
14. Schalin-Jäntti CS, Härkönen M, Groop LC (1992) Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 41: 598-604
15. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest 89: 1069-1075
16. Kahn CR (1994) Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066-1084
17. King SR, Tempesta MS (1994) From shaman to human clinical trials: the role of industry in ethnobotany, conservation and community reciprocity. In Chadwick DJ, Marsh J (eds) Ethnobotany and the search for new drugs. Ciba Foundation Symposium 185. John Wiley and Sons Chichester/ New York pp. 197-213
18. Cox PA (1994) The ethnobotanical approach to drug discovery: strength and limitations. In: Chadwick DJ, Marsh J (eds) Ethnobotany and the search for new drugs. Ciba Foundation Symposium 185. John Wiley and Sons Chichester New York pp. 25-36
19. Cox PA, Balick MJ (1994) The ethnobotanical approach to drug discovery. Scientific American June, pp. 82-87
20. King S, Carlson T (1995) Biocultural diversity, biomedicine and ethnobotany: the experience of Shaman Pharmaceuticals. Interciencia, Revista de Ciencia y Tecnologia de America [Journal of Science and Technology of the Americas]. 20: 134-139
21. Daly DC, Limbach CG (1996) The contribution of the physician to medicinal plant research. In: Balick MJ, Elisabetsky E, Laird SA (eds) Medicinal resources of the tropical forest: biodiversity and its importance to human health. Columbia University Press New York
22. Conte LA (1996) Shaman Pharmaceuticals' approach to drug development. In: Balick MJ, Elisabetsky E, Laird SA (eds) Medicinal resources of the tropical forest: biodiversity and its importance to human health. Columbia University Press New York
23. King SR, Tempesta MS (1994) From shaman to human clinical trials: the role of industry in ethnobotany, conservation and community reciprocity. In: Chadwick DJ, Marsh J (eds) Ethnobotany and the search for new drugs Ciba Foundation Symposium 185. John Wiley and Sons, Chichester/ New York pp. 197-213